• Title/Summary/Keyword: HRSD

Search Result 15, Processing Time 0.023 seconds

Synergistic Effect of Forest Environment and Therapeutic Program for the Treatment of Depression (산림활동이 우울증 환자들의 호전에 미치는 영향: 산림치유 프로그램 집단과 병원 프로그램 집단, 산림욕 집단, 대조군 비교 연구)

  • Woo, Jong-Min;Park, Sang Mi;Lim, Seong Kyeon;Kim, Won
    • Journal of Korean Society of Forest Science
    • /
    • v.101 no.4
    • /
    • pp.677-685
    • /
    • 2012
  • This study was conducted to evaluate the effect of forest environment and therapeutic program to the patients with major depressive disorder in antidepressant medication. The first group participated the four sessions of therapeutic program in the forest environment ("forest therapy"), the second group did in the program in a hospital environment, the third group did merely walking in the forest ("forest bath"), and the last group was controls. All the participants was diagnosed with major depressive disorder and had been taking antidepressant medication longer than 3 months. Depressive symptoms were measured by the Hamilton Rating Scales for Depression(HRSD), Montgomery-Asberg Depressin Rating Scales(MADRS), Beck Depression Inventory(BDI), and general health perception was measured by Short Form Health Survey Questionnaire(SF-36). Heart rate variability(HRV) were also examined to observe the physiological parameters before and after the program. In the results, HRSD score of forest program group was significantly lower than controls after the program. MADRS score of forest therapy group and hospital program group was also significantly lower than controls after 4 sessions of the program. The remission rate defined as below 7 points in HRSD was higher in the forest therapy group, hospital program group, forest bath group, and controls in order. These results reveals that the therapeutic program performed in forest environment may improve unremitted depressive symptoms of patients with major depressive disorder. Although not significant, the forest therapy program showed better outcome than hosptial program and forest bath.

One Clinical Case Report of Lung Cancer Patient with Depression and Anxiety Disorder Improved by Korean Traditional Medical Treatment and Breathing Meditation (한방치료와 호흡명상으로 호전된 폐암 환자의 불안 및 우울 증상 치험 1례)

  • Gu, Ja-Hwan;Kim, Se-Ran;Im, Eun-Young;Kim, Soo-Hyun;Kim, Jong-Dae
    • Journal of Physiology & Pathology in Korean Medicine
    • /
    • v.25 no.6
    • /
    • pp.1102-1107
    • /
    • 2011
  • This study was case report to show the good effects of korean traditional medical treatment and breathing meditation. The methods were applied to lung cancer patients. We treated one patient who scored 27 point at Beck's depression inventory(BDI) and 28 point at Hamilton rating scale for depression(HRSD) and 22 point at Beck's anxiety inventory(BAI) and 20 point at Anxiety status inventory(ASI) by korean traditional medical treatment and breathing meditation. After treatment, the clinical symptoms were improved and the score of BDI, HRSD, BAI, ASI were decreased. According to this study korean traditional medical treatment is effective for the cure of depression and anxiety disorder and breathing meditation forifies the korean traditional medical treatment.

A Study on Bibliotherapy for Depressed Older Adults (노인의 우울증 해소를 위한 독서요법연구)

  • Yu Hae-Sook
    • Journal of the Korean Society for Library and Information Science
    • /
    • v.33 no.1
    • /
    • pp.5-22
    • /
    • 1999
  • This research aimed at the investigation of the effectiveness of bibliotherapy for depressed older adults 65 years of age and older, The efficacy between interactive bibliotherapy and reading bibliotherapy was also compared and analysed. For implementing the research, 22 subjects, aged 65 or over. were recruited from the community on a volunteer basis to Participate in a bibliotherapy program. Initial screening of potential participants was conducted by testing the measurement of depression. Experiment results were analyzed via t-ananlysis(SD, P, T) and $2\times3(Group{\times}Time)$ between and within ANOVA calculated by SPSS program. The results of the analyses supported hypotheses 1, 2, and 3, focusing the efficacy of interactive bibliotherapy as well as reading bibliotherapy. The analysis of hypothesis 4 was revealed that the effectiveness of interactive bibliotherapy was superior to that of reading bibliotherapy in the score of BDI and HRSD, while there was no statistical significance in the score of DAS.

  • PDF

Changes of Positive Symptoms, Negative Symptoms and Depressive Symptoms after Adjuntive Fluoxetine Trial in Schizophrenic Patients (정신 분열증 환자에서 Fluoxetine 투여에 따른 양성증상, 음성 증상 및 우울 증상의 변화)

  • Choi, Won;Jung, Han Yong;Han, Sun Ho
    • Korean Journal of Biological Psychiatry
    • /
    • v.3 no.1
    • /
    • pp.75-82
    • /
    • 1996
  • Object : The aim of this study was to evaluate the changes of positive stmtoms. negative symptoms, and depressive symptoms after fluoxetine trial in haloperidol-stabilized schizophrenic in-patients. Method : Fluoxetine(20mg/day) was added for 6weeks to stable doses of haloperidol given to 32 schizophrenic in-patients. The subjects was divided into positive and negative schizophrenics by PANSS. The authors checked PANSS. HRSD at baseline, the 2nd week. the 4th week, the 6th week of treatment. Result were as follows : 1) In all subjects, positive and depressive symptoms were significantly improved. 2) As time went on, positive and negative symptoms were not significantly improved in positive and negative schizophrenics. 3) As time went on, depressive symptoms were not significantly improved in positive and negative schizophrenics. Conclusion : We suggested that fluoxetine may be useful in the treatment of positive symptoms in schizophrenia and, It may be due to the effect on the serotonin system and the interaction between serotonin and dopamine system.

  • PDF

Changes of Hamilton Rating Scale for Depression According to Plasma 5-Hydroxyindoleacetic Acid Level after Adjuntive Fluoxetine Trial in Schizophrenic Patients (Fluoxetine 병용 투여 후 만성 정신분열증 환자에서 혈장 5-Hydroxyindoleacetic Acid 농도에 따른 Hamilton Rating Scale for Depression의 변화)

  • Shim, Se Hoon;Jung, Han Yong;Han, Sun Ho
    • Korean Journal of Biological Psychiatry
    • /
    • v.3 no.2
    • /
    • pp.269-276
    • /
    • 1996
  • Object : The aim of this study was to examine an association between plasma 5-Hydroxyindoleacetic Acid(HIAA) level and the change of depressive symptom after fluoxetine trial in haloperidol-stabilized schizoprenic in-patients. Method : According to plasma 5-HIM level, 32 patients were classified to either group with high 5-HIAA level(N=11) or that with low 5-HIM(N=11). For each patient, fluoxetine(20mg/day) added to stable haloperidol dose for 6 weeks. The authors measured Hamilton Rating Scale for Depression (HRSD) at baseline, the 2nd week, the 4th week, the 6th week of treatment. Result : 1) Age, duration of illness, number of admission, duration of present admission, dosage of haloperidol between high 5-HIAA group and low 5-HIM group were significantly different. 2) As time went on, the association between the change of depressive symptom and plasma 5-HIAA concentration was not significant. 3) Of depressed group, as lime went an, depressive symptoms were improved significantly in high 5-HIAA group, but not in law 5-HIM group. Conclusion : We suggest that the association between plasma 5-HIAA level and the change of depressive symptoms after fluoxetine trial in haloperidol stabilized schizophrenic in-patients was not significant.

  • PDF

Co-administration of Paroxetine and Haloperidol : Changes of Symptoms and Blood Level of Haloperidol, Reduced Haloperidol (만성 정신분열증 환자에서 Paroxetine과 Haloperidol 병합투여시 정신병리증상과 Haloperidol, Reduced Haloperidol 혈중농도의 변화)

  • Han, Chang Su;Lee, Min Soo;Kim, Pyo Han
    • Korean Journal of Biological Psychiatry
    • /
    • v.3 no.2
    • /
    • pp.251-257
    • /
    • 1996
  • Selective serotonin reuptake inhibitors(SSRIs), as haloperidol, ore metabolized in the cytochrome P450IID6. They can cause inhibition of metabolism of antipsychotics to elevate the serum level of antipsychotics and exacerbate the extrapyramidal symptoms when co-administered with antipsychotics. Among these SSRIs, there ore a few studies about paroxetine compared to fluoxetine or sertraline. In this study, we have intended to know the drug interaction of paroxetine and haloperidol when co-administered two drugs for the chronic schizophrenics by assessing the changes of positive, negative symptoms and extrapyramidal symptoms. for this purpose, we selected 29 subjects, the chronic schizophrenics with no physical problems. They were under maintenance therapy of haloperidol. They ore randomly assigned to placebo group(n=12) and drug group(n=17) by using double blind method. And then, placebo or paroxetine 20mg were administered to the subjects of each groups during 8 week period. We have assessed their psychopathology and extrapyramidal symptoms using Positive and Negative Syndrome Scale(PANSS), Hamilton Rating Scale lor Depression(HRSD), Simpson-Angus Scale at 0, 2, 4, 6, 8 weeks and serum haloperidol, reduced haloperidol levels at 0, 4, 8 weeks during the period. The results ore analysed by using repeated measure MANOVA. 27 subjects have completed the study during 8 weeks. among the subjects, 1) PANSS, HRSD ; no significant difference between groups. 2) Simpson-Angus Scale ; no significant change according to the time and no significant difference between the groups(no group and time effect). 3) Haloperidol and reduced haloperidol level ; no significant change. When co-administered paroxetine and haloperidol, there ore no significant changes of the psychopothology and no significant changes of the extrapyramidal symptoms. In this result, paroxetine seems to be not to affect the metabolism of haloperidol.

  • PDF

Plasma Serotonin Level of Vietnam War Veterans with Post-Traumatic Stress Disorder and Symptom Severity (혈장 세로토닌과 외상후 스트레스 장애 : 월남전 참전 재향군인을 대상으로)

  • Lee, Soo-Young;Kang, Suk-Hoon;Chung, Moon-Yong;Lee, Myung-Hee;Kim, Tae-Young;So, Hyung-Seok;Chung, Hae-Kyung;Choi, Jin-Hee
    • Anxiety and mood
    • /
    • v.5 no.1
    • /
    • pp.14-20
    • /
    • 2009
  • Objective : The objective of this study was to examine the relationship between plasma serotonin concentration and posttraumatic stress disorder (PTSD) symptoms in chronic PTSD patients who have been taking medication. Methods : Plasma serotonin level of 14 PTSD patients and a control group of 28 Vietnam War veterans was measured by HPLC (high performance liquid chromatography). The Combat Exposure Scale (CES), Mississippi Scale for Combat-Related Posttraumatic Stress Disorder (M-PTSD), Clinician Administered PTSD Scale (CAPS), Hamilton Rating Scale for Depression (HRSD), and Hamiltion Anxiety Scale (HAS) were used to evaluate PTSD symptom severity. Results : Serotonin level was significantly higher in the PTSD group than in the control group (p=0.036, p=0.006, respectively). M-PTSD (p<0.001), CAPS (p<0.001), HRSD (p<0.001), and HAS (p<0.001) scale scores were significantly higher in the PTSD group than in the control group; however, the CES score failed to show a significant improvement (p=0.964). There were no significant differences between plasma serotonin and PTSD symptoms. Conclusion : In chronic PTSD patients who have been taking medications, we can not predict treatment effect and symptom severity by measuring only plasma serotonin levels. PTSD is a complicated disorder which may likely be related to a variety of neurotransmitter systems. Therefore, further research which investigate relationships with norepinephrine, dopamine, and other neurotransmitters as well as serotonin is needed to improve the treatment of PTSD.

  • PDF

Preliminary Study on the Usefulness of Psychological Scale Measurements in Depression Symptoms (우울증상에 대한 심리척도의 유용성에 대한 기초연구 -비우울증, 화병과의 비교를 중심으로-)

  • Choi, Woochang;Kim, Nahyun;Choi, Sungwon;Jung, Inchul
    • Journal of Oriental Neuropsychiatry
    • /
    • v.24 no.4
    • /
    • pp.363-372
    • /
    • 2013
  • Objectives: The purpose of this study is to investigate the usefulness of psychological measurements in depression symptoms as compared with non-depressions and hwabyung. Methods: A total of 21 patients, who were diagnosed with depression and hwabyung, were evaluated by using the SCL-90-R, BDI, STAI, STAXI, ISI, HRSD, 20-Item Alexithymia Scale, BSDS and NEO-PI. Thereafter, they were statistically analyzed. Results: 1) In the results of SCL-90-R, the PST score group of hwa-byung group without depression was significantly higher when compared to the score from the depression group without hwa-byung. 2) In the results of NEO-PI, the NEO-PI-O score of hwa-byung group without depression was significantly higher when compared to the score from the depression group without hwa-byung. 3) In the results of 20-Item Alexithymia Scale, the total score and score of difficulty for identifying feelings scale from the depression group was significantly higher when compared to the score of non depression group. Conclusions: The results found are expected to serve as a useful resource for future studies when developing the instruments of oriental medical evaluations for hwa-byung.

A study for diagnosis and pattern identification of Hwa-Byung (화병의 진단 및 변증유형에 관한 연구)

  • Lee, Hui-Young;Park, Jong-Hoon;Whang, Wei-Wan;Kim, Jong-Woo
    • Journal of Oriental Neuropsychiatry
    • /
    • v.16 no.1
    • /
    • pp.1-17
    • /
    • 2005
  • Objective : This empirical research is performed to recognize diagnostic concept, pattern identification, and clinical features of Hwa-byung. In other words, the aims of this research are to examine the differences of the diagnosis between Hwa-Byung and the other psychiatric disorders, and to find out pattern identification, and clinical characteristics of Hwa-Byung for prescriptions of this syndrome. Method : In the experiment, there were participated 30 patients who were met for our criterions according to HBDIS (Hwa-Byung Diagnostic interview Schedule). These patients were diagnosed as Axis1 according to criterions of DSM-IV with administering SCID-I. OMS-prime was utilized for finding out pattern identification of oriental medicine. Symptom Check List-90-Revision(SCL-90-R), Hemilton rating Scale for Depression(HRSD), Heart Rate Variability(HRV), and Digital Infrared Thermographic imaging(D.I.T.I.) were also utilized to discover clinical characteristics of Hwa-Byung Patients. Results : 1. Regarding Sex-ratio, male subjects were 3(10%), and female subjects are 27(90%). The age of subjects ranged from 22 year old to 75 $(51.87{\pm}11.04;\:Mean{\pm}SD)$ 2. In the results of diagnosis on the basis of DSM-IV, the 17(56.67%) patients were MOD (Major Depressive Disorder), the 5(16.67%) patients were USD (Undifferentiated Somatoform Disorder), the 4(13.33%) patients were Dysthymic Disorder, the 3(10%) patients were GAD (Generalized Anxiety Disorder), and the 1(3.33%) was Panic Disorder. Two of the patients who diagnosed as MOD were diagnosed as Panic Disorder too, and one of them was diagnosed as Pain Disorder too. 3. Regarding pattern identification, Hwa-Byung is positively correlated to deficiency of Heart(心). and then to stagnancy of Liver-Gall bladder. Hwa-Byung is correlated deficiency symptom-complex rather than excessiveness symptom-complex. That is also correlated positively to Pathological heat and fire. 4. In SCL90-R, the mean of PSDI was $(75.3{\pm}10.7;\:Mean{\pm}SD)$. The each mean of the other 11 factors was distributed between50-70. 5. The mean of HRSD was $(17.9{\pm}5.6;\:Mean{\pm}SD)$ in the entire subject's group. Then the group of MDD was $20.9{\pm}4.4$ and the group of USD was $12.0{\pm}4.8$ 6. In the results of HRV. the mean of TP is $972.4{\pm}1174(Mean{\pm}SD)$, this is lower than normal range 1000-200. The other factors were within normal range. Then, there were no significant differences between them (p<0.05). 7. The temperatures of each acupoint have significant differences between HNl(印堂) and PC6(內關), between CV17(顫中) and PC6(內關), between HN1(印堂) and CV8(神闕), between CV17(顫中) and CV8(神闕) in comparison with the average of body temperature in the use of D.I.T.I. (p<0.01) 8. In the analysis of correlation between SCL-90-R, HRSD, HRV. and D.I.T.I. there were no significant results. According to results that the correlation was analyzed with only the MDD group as subjects, there was negative correlation between RMSSD of HRV and HRSD, between LF of HRV and PDSIof SCL-90-R, and between LF/HF of HRV and ANX, PSY, and PDSI of SCL-90-R. Conclusion : In the observation of clinical features of 30 cases of Hwa-Byung patients by using diverse structured tests, there could make diverse diagnosis as depressive disorder, anxiety disorder, and Somatoform Disorder. Particularly. MDD was highly distributed. Considering oriental medicine's pattern identification of Hwa-Byung, this syndrome is related strongly to Heart, and there were demonstrated deficiency symptom-complex, and Pathological heat and fire. One of the limits of this study is lack of control subject's group, therefore, in the future study, it requires reexamination through a comparative research with these data to complete this study.

  • PDF

Two Case Report of UL-syndrome(鬱症) Treated with Gamisoyosan(加味逍遙散) (가미소요산(加味逍遙散)으로 호전된 여성 울증 환자 치험 2례)

  • Je, Yun-Mo;Yoo, Dong-Youl
    • Journal of Haehwa Medicine
    • /
    • v.19 no.2
    • /
    • pp.187-193
    • /
    • 2011
  • Purpose : This paper is aim to report the effects of Gamisoyosan(加味逍遙散) on the UL-syndrome(鬱症) Methods : This is two cases report of female patient suffering from headache, chest discomfort, heart burning, insomnia, dyspepsia, anorexia, fatigue and other symptoms due to chronic stress. 52 years old woman who diagnosed UL-syndrome(鬱症) was enrolled in this study. We gave her Gamisoyosan(加味逍遙散) 2 times, each for 3 weeks. During the treatments, we check changes of symptoms and HRSD. Results : After the oriental medical treatments, symptoms of UL-syndrome(鬱症) were decreased or disappeared. Conclusion : This clinical case indicate that Gamisoyosan(加味逍遙散) is effective in treatment of the depression disorder and symptoms of UL-syndrome(鬱症). More clinical data and studies are requested for the treatment of UL-syndrome(鬱症).